Photo via The Guardian

Royal College of Nursing cuts ties with Israeli drug company

Read the original at The Guardian ↗
Cite

Campbell, D. (2026, October 2). Royal College of Nursing cuts ties with Israeli drug company. The Guardian. https://www.theguardian.com/society/2026/oct/02/royal-college-of-nursing-cuts-ties-with-israeli-drug-company

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Guardian · collected 2026-10-02 · by Denis Campbell

Quick Summary

The Royal College of Nursing (RCN) has ended its commercial relationship with Teva UK, an Israeli drug company, following pressure from pro-Palestine groups who argue that Teva’s links to Israel’s military and history of corporate misconduct are incompatible with RCN values. The decision affects upcoming events and sponsorship agreements but does not impact the NHS's ongoing use of Teva’s medicines. Campaigners view this as a significant victory for their movement aimed at isolating Israel, while Teva expresses disappointment over what it sees as politicization of healthcare.
Written by AI on 2026-10-02, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The Royal College of Nursing (RCN) in Britain has ended its commercial relationship with Teva UK, an Israeli drug company, due to pressure from pro-Palestinian groups like Nurses for Palestine and the UK Healthcare Petitions to Royal Colleges (UKHPRC). The RCN represents over 500,000 nurses in the UK and cited concerns about Teva's links to Israel’s military and history of corporate misconduct. Campaigners hailed this decision as a significant victory for the international boycott movement aimed at isolating Israel globally. Carmel O’Boyle, chair of RCN’s ruling council, confirmed the move in correspondence with Nurses for Palestine, stating that Teva UK will no longer sponsor an upcoming event on migraine and headaches at the RCN headquarters in London.

Written for “Israeli Drug Company Controversy” on 2026-11-05, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Israeli Drug Company Controversy
Politics · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
22
sentences that state something as happening or true
Uncertain
0%
0 of 22 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
66/100
The Guardian's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-02 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Guardian · 3007 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Denis Campbell
5 article(s) here · 1 carrying a prediction
🔮 She would therefore be expected to advise ministers on how best to strengthen the regulation of private providers of ADHD and autism services.
🔮 While we respectfully disagree with this decision, we will continue to act with integrity and remain focused on what matters most: helping patients access the medicines they need.
🔮 The experts behind the review also called for access to care to be based primarily on a person’s needs so fewer people would have years-long waits for a formal diagnosis.
🔮 The event will go ahead as planned,” she said.
🔮 Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful.
Also by Denis Campbell
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Nurses for Palestine Palestine RCN Teva Teva UK

Subjects

RCN ORG · 10× Teva UK ORG · 7× Teva ORG · 5× Nurses for Palestine ORG · 3× Palestine GPE · 2× RCNi ORG · 2× UKHPRC ORG · 2× the European Commission ORG · 2× the US Department of Justice ORG · 2× Britain GPE · 1×

Narrative

UKHPRC said: “It is unthinkable that in this day and age healthcare organisations continue to enter into commercial relationships with companies linked to sustaining state systems accused or found by international bodies to involve grave violations of international law, including crimes against humanity, apartheid and genocide.”
framing: assertive · carried by 1 article(s) · first seen 2026-10-02
🔮 The event will go ahead as planned,” she said.
2026-10-02 · The Guardian
Royal College of Nursing cuts ties with Israeli drug company · assertive framing

Claims (22 extracted, 0 hedged)

Britain’s nursing union has cut its ties with an Israeli drug company over the firm’s links to the country’s military and track record of corporate misconduct. asserted
union → cut → misconduct
The Royal College of Nursing (RCN) has axed Teva UK as a commercial partner and as sponsor of a forthcoming event on migraine and headaches at the union’s London headquarters. asserted
College → ax → headquarters
Pro-Palestine groups who were pushing the RCN to drop Teva UK claimed the decision was “a major breakthrough for grassroots healthcare organising and the international boycott, divestment and sanctions movement” aimed at isolating Israel worldwide. asserted
decision → push → Israel
The RCN represents more than 500,000 nurses in the UK. asserted
RCN → represent → UK
It acted after coming under pressure from campaign groups Nurses for Palestine and UK Healthcare Petitions to Royal Colleges (UKHPRC) to end its relationship with Teva UK. asserted
It → act → UK
Carmel O’Boyle, the chair of the RCN’s ruling council, confirmed the decision in a letter to Nurses for Palestine. asserted
O’Boyle → rule → Palestine
“Going forward [the] RCN is ending its commercial partnership with Teva UK. asserted
RCN → go → UK
The event will go ahead as planned,” she said. asserted
she → go → ?
“We are taking this action because further due diligence showed that there are a number of Teva Pharmaceuticals’ operations, which have been the subject of legal sanction and public scrutiny, which are not in line with RCNi [the union’s publishing and education arm] and RCN values. asserted
which → take → RCNi
“We know how important it is that the RCN only enters commercial relationships with companies that represent the values of the nursing profession.” asserted
that → know → profession
Teva said it was “disappointed” at the RCN’s decision and that healthcare had been “politicised”. asserted
healthcare → say → decision
Nurses for Palestine welcomed the move. asserted
Nurses → welcome → move
“Teva has no place sponsoring professional bodies dedicated to healing, care and preserving human life,” a spokesperson said. asserted
spokesperson → have → life
UKHPRC said: “It is unthinkable that in this day and age healthcare organisations continue to enter into commercial relationships with companies linked to sustaining state systems accused or found by international bodies to involve grave violations of international law, including crimes against humanity, apartheid and genocide.” asserted
organisations → say → humanity
Pro-Palestine campaigners are now calling on the Royal College of Pharmacy to drop Teva UK as a sponsor of its annual conference next month and cancel the exhibition stand the firm has booked. asserted
firm → call → stand
Teva has been ordered to pay about £1bn in fines and other payments by the European Commission and US authorities over the last decade for bribery, price-fixing and abuse of its market position. asserted
Teva → order → position
In 2024 the European Commission fined Teva €462.6m for blocking rival firms from competing with Copaxone, its treatment for multiple sclerosis, in seven European countries for between four and nine years. asserted
Commission → fin → years
In 2023 it agreed with the US Department of Justice to pay $225m in fines as an alternative to prosecution after it was charged with fixing the price of three drugs. asserted
it → agree → drugs
And in 2016 it struck a deal with the US Securities and Exchange Commission and the US Department of Justice to pay $519m to settle civil and criminal charges involving its bribery of government officials in Russia, Ukraine and Mexico. asserted
it → strike → Russia
A Teva spokesperson said: “As one of the largest suppliers of medicines to the UK we have valued our longstanding partership with the RCN and the opportunity it has provided to support healthcare professionals and the patients they care for. asserted
they → say → professionals
“We are disappointed by the RCN’s decision to end this relationship and are seeking further dialogue with the organisation. asserted
We → disappoint → organisation
Healthcare is at its best when it remains focused on patients rather than being politicised.” asserted
it → remain → patients
💬Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

🕘History 🎫Support